Biopharmaceutical Company Announces Preclinical Data For Chronic Neuropathic Epilepsy
Trevena's Preclinical Findings: TRV045 in Neuropathic Pain and Epilepsy Models.
Disclaimer: This article is for informational purposes only and should not be construed as professional medical advice. The content is based on preclinical data and ongoing research, and its conclusions are subject to further validation through clinical trials. Consult healthcare professionals for any medical concerns or question…